THE FIRM This 14-lawyer practice stands out for its activity in pharmaceutical product liability matters, and also handles commercial litigation, competition, regulatory and corporate work. It handled a number of high-profile matters of late, including major equity capital markets transactions, cross-border M&A, global licensing agreements, blockbuster patent infringements and competition authority raids. The team also advises on clinical trial agreements, medical advertising regulation, pharmaceutical trade marks, corporate governance, and tax and employment matters. Highlights include advising a global medical devices company on a tax-driven restructuring, which involved co-ordinating the transfer of shares and contributions of affiliates across ten jurisdictions. The group also advised an Asian pharma company on its auction bid for the acquisition of a worldwide portfolio of products, which required a multidisciplinary team formed from the corporate, competition, employment and IP departments.
Sources say: "It is clearly a top firm in this area, providing great quality work and internationally established experience – the best group in the market in terms of product liability."
KEY INDIVIDUALS Celebrated lawyer Jacques-Antoine Robert leads the firm's life sciences and litigation practice, and remains an incontestable market leader in pharmaceutical product liability. He is also recognised for his extensive work in regulatory, competition and commercial litigation, advising many of the top global pharma companies. Sources describe him as "a clearly outstanding litigator and lawyer – both famous and respected."
Younger partner Alexandre Regniault maintains his market position and is highlighted for his growing visibility in this field. He advises pharma and biotech names on a range of matters, including contentious, regulatory and transactional issues.